Tesha Monteith

Dr. Tesha Monteith, a dedicated migraine researcher, joins Dr. Messoud Ashina, an expert in migraine treatment, to delve into a groundbreaking phase two study on a monoclonal antibody targeting PACAP for migraine prevention. They highlight its efficacy and safety compared to placebo, address the pressing need for new treatments, and share insights on reported adverse effects. The discussion also hints at exciting future research directions that could transform migraine management. This is vital listening for anyone interested in migraine solutions!

Dr. Tesha Monteith, a PACAP biology expert, and Dr. Messoud Ashina, a migraine therapy specialist, delve into the revolutionary role of PACAP in migraine prevention. They discuss a groundbreaking study on a monoclonal antibody targeting PACAP, revealing its crucial functions in migraine triggers. The two also explore PACAP's vasodilatory effects and how intravenous PACAP infusion impacts specific arteries. Tune in for insights on potential new therapeutic approaches that could change migraine management forever!

Dr. Tesha Monteith, an expert on PACAP biology, joins Dr. Messoud Ashina, a specialist in migraine therapies, to discuss groundbreaking research on monoclonal antibodies for migraine prevention. They dive into PACAP's crucial role in migraine development and the challenges of treatment research. The conversation includes insights from recent clinical trials assessing the effectiveness of PACAP-targeted therapies, the potential for combination treatments, and the future of migraine management. An engaging exploration of a promising new frontier in headache treatment!

Dr. Tesha Monteith, a migraine treatment expert, teams up with researcher Richard B. Lipton to explore the effects of Ubrogepant on migraines. They dive into a recent study highlighting how Ubrogepant can dramatically enhance patient-reported outcomes during the migraine prodrome phase. With significant boosts in functioning and patient satisfaction compared to a placebo, this discussion sheds light on innovative approaches in migraine care.

Dr. Tesha Monteith, an expert on long COVID, delves into its defining characteristics and impact on neurology. She explains that symptoms can arise after any COVID-19 infection, even asymptomatic cases. The discussion highlights the profound effects on emotional health and daily functionality, underscoring the urgency for neurologists to stay abreast of evolving research. Monteith's insights illuminate the ongoing challenges faced by many individuals grappling with long COVID.